Updated on 2025/08/01

All information, except for affiliations, is reprinted from the information registered on researchmap.

写真a

 
Mai Hatano
 
Organization
Graduate School of Medicine Department of Medicine Physiology Assistant Professor
School of Medicine Medical Course
Title
Assistant Professor
Profile

幼少期から、脳卒中によって寝たきりとなった祖父母の介護を経験する中で、「たとえ慢性期であっても回復が見込める薬があればいいのに」と強く思うようになり、その思いがきっかけで研究職を志すようになりました。

2017年より、脳内AMPA受容体に着目し、精神・神経疾患の病態解明を目的とした研究に取り組んでいます。AMPA受容体を特異的に標識するPET薬剤[¹¹C]K-2の開発に携わり、その安全性および特異性を証明しました(Miyazaki et al., 2020;Hatano et al., 2021)。

2024年には、[¹¹C]K-2を用いてうつ病、双極性障害、統合失調症、自閉スペクトラム症(ASD)におけるAMPA受容体の脳内分布を明らかにし、症状に関連する脳領域や、疾患横断的に変化する可能性のある「気質」的脳領域を特定し、その成果を論文として発表しました(Hatano et al., 2024)。

現在は、[¹¹C]K-2を用いたうつ病と双極性障害の鑑別プログラムの開発や、認知症における縦断的PET画像解析にも取り組んでいます。

今後は疾患研究にとどまらず、健常脳における加齢変化をAMPA受容体の観点から明らかにし、認知症の発症メカニズム解明に資することを目指しています。加えて、更年期障害や月経前症候群といった女性特有の疾患にも注目し、一見すると日常生活を送れているように見えても、目に見えない苦しみを抱えている方々の支援につながる研究を進めていきたいと考えています。

External link

Research Interests

  • Positron Emission Tomography (PET)

  • てんかん

  • 精神疾患

  • AMPA受容体

  • MRI・PET画像解析

Education

  • Yokohama City University   Graduate School of Medicine

    2019.4 - 2022.3

      More details

Research History

  • Yokohama City University   School of Medicine Medical Course Physiology   Assistant Professor

    2024.5

      More details

  • Yokohama City University

    2022.4 - 2024.4

      More details

Papers

  • First-in-Human Study of<sup>18</sup>F-Labeled PET Tracer for Glutamate AMPA Receptor [<sup>18</sup>F]K-40: A Derivative of [<sup>11</sup>C]K-2

    Sadamitsu Ichijo, Tetsu Arisawa, Mai Hatano, Waki Nakajima, Tomoyuki Miyazaki, Tsuyoshi Eiro, Yuuki Takada, Ryunosuke Iai, Akane Sano, Masaki Sonoda, Yutaro Takayama, Yuichi Kimura, Takuya Takahashi

    Journal of Nuclear Medicine   66 ( 6 )   932 - 939   2025.5

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Society of Nuclear Medicine  

    DOI: 10.2967/jnumed.124.269405

    researchmap

  • α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor density underlies intraregional and interregional functional centrality

    Taisuke Yatomi, Dardo Tomasi, Hideaki Tani, Shinichiro Nakajima, Sakiko Tsugawa, Nobuhiro Nagai, Teruki Koizumi, Waki Nakajima, Mai Hatano, Hiroyuki Uchida, Takuya Takahashi

    Frontiers in Neural Circuits   18   2024.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Local and global functional connectivity densities (lFCD and gFCD, respectively), derived from functional magnetic resonance imaging (fMRI) data, represent the degree of functional centrality within local and global brain networks. While these methods are well-established for mapping brain connectivity, the molecular and synaptic foundations of these connectivity patterns remain unclear. Glutamate, the principal excitatory neurotransmitter in the brain, plays a key role in these processes. Among its receptors, the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is crucial for neurotransmission, particularly in cognitive functions such as learning and memory. This study aimed to examine the association of the AMPAR density and FCD metrics of intraregional and interregional functional centrality. Using [<sup>11</sup>C]K-2, a positron emission tomography (PET) tracer specific for AMPARs, we measured AMPAR density in the brains of 35 healthy participants. Our findings revealed a strong positive correlation between AMPAR density and both lFCD and gFCD-lFCD across the entire brain. This correlation was especially notable in key regions such as the anterior cingulate cortex, posterior cingulate cortex, pre-subgenual frontal cortex, Default Mode Network, and Visual Network. These results highlight that postsynaptic AMPARs significantly contribute to both local and global functional connectivity in the brain, particularly in network hub regions. This study provides valuable insights into the molecular and synaptic underpinnings of brain functional connectomes.

    DOI: 10.3389/fncir.2024.1497897

    researchmap

  • Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography

    Mai Hatano, Waki Nakajima, Hideaki Tani, Hiroyuki Uchida, Tomoyuki Miyazaki, Tetsu Arisawa, Yuuki Takada, Sakiko Tsugawa, Akane Sano, Kotaro Nakano, Tsuyoshi Eiro, Hiroki Abe, Akira Suda, Takeshi Asami, Akitoyo Hishimoto, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Shunya Kurokawa, Yohei Ohtani, Kie Takahashi, Yuhei Kikuchi, Taisuke Yatomi, Shiori Honda, Masahiro Jinzaki, Yoji Hirano, Ryo Mitoma, Shunsuke Tamura, Shingo Baba, Osamu Togao, Hirotaka Kosaka, Hidehiko Okazawa, Yuichi Kimura, Masaru Mimura, Takuya Takahashi

    Molecular Psychiatry   2024.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Synaptic phenotypes in living patients with psychiatric disorders are poorly characterized. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a fundamental component for neurotransmission. We recently developed a positron emission tomography (PET) tracer for AMPAR, [<sup>11</sup>C]K-2, the first technology to visualize and quantify AMPARs density in living human brain. In this study, we characterized patients with major psychiatric disorders with [<sup>11</sup>C]K-2. One hundred forty-nine patients with psychiatric disorders (schizophrenia, n = 42; bipolar disorder, n = 37; depression, n = 35; and autism spectrum disorder, n = 35) and 70 healthy participants underwent a PET scan with [<sup>11</sup>C]K-2 for measurement of AMPAR density. We detected brain regions that showed correlation between AMPAR density and symptomatology scores in each of four disorders. We also found brain areas with significant differences in AMPAR density between patients with each psychiatric disorder and healthy participants. Some of these areas were observed across diseases, indicating that these are commonly affected areas throughout psychiatric disorders. Schizophrenia, bipolar disorder, depression, and autism spectrum disorder are uniquely characterized by AMPAR distribution patterns. Our approach to psychiatric disorders using [<sup>11</sup>C]K-2 can elucidate the biological mechanisms across diseases and pave the way to develop novel diagnostics and therapeutics based on the synapse physiology.

    DOI: 10.1038/s41380-024-02785-1

    researchmap

    Other Link: https://www.nature.com/articles/s41380-024-02785-1

  • てんかん病態を制御する脳内AMPA受容体の動態

    永露 毅, 宮崎 智之, 波多野 真依, 中島 和希, 有澤 哲, 高田 由貴, 木村 キミト, 野田 賀大, 内田 裕之, 木村 裕一, 高橋 琢哉

    核医学技術   43 ( 予稿集 )   321 - 321   2023.10

     More details

    Language:Japanese   Publisher:(NPO)日本核医学技術学会  

    researchmap

  • Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy. International journal

    Tsuyoshi Eiro, Tomoyuki Miyazaki, Mai Hatano, Waki Nakajima, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Akane Sano, Kotaro Nakano, Takahiro Mihara, Yutaro Takayama, Naoki Ikegaya, Masaki Iwasaki, Akitoyo Hishimoto, Yoshihiro Noda, Takahiro Miyazaki, Hiroyuki Uchida, Hideaki Tani, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Masaru Mimura, Nozomu Matsuda, Kazuaki Kanai, Kazuhiro Takahashi, Hiroshi Ito, Yoji Hirano, Yuichi Kimura, Riki Matsumoto, Akio Ikeda, Takuya Takahashi

    Cell reports. Medicine   4 ( 5 )   101020 - 101020   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) contribute to epileptogenesis. Thirty patients with epilepsy and 31 healthy controls are scanned using positron emission tomography with our recently developed radiotracer for AMPARs, [11C]K-2, which measures the density of cell-surface AMPARs. In patients with focal-onset seizures, an increase in AMPAR trafficking augments the amplitude of abnormal gamma activity detected by electroencephalography. In contrast, patients with generalized-onset seizures exhibit a decrease in AMPARs coupled with increased amplitude of abnormal gamma activity. Patients with epilepsy had reduced AMPAR levels compared with healthy controls, and AMPARs are reduced in larger areas of the cortex in patients with generalized-onset seizures compared with those with focal-onset seizures. Thus, epileptic brain function can be regulated by the enhanced trafficking of AMPAR due to Hebbian plasticity with increased simultaneous neuronal firing and compensational downregulation of cell-surface AMPARs by the synaptic scaling.

    DOI: 10.1016/j.xcrm.2023.101020

    PubMed

    researchmap

  • Epileptic discharges initiate from brain areas with elevated accumulation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors. International journal

    Tomoyuki Miyazaki, Yutaro Takayama, Masaki Iwasaki, Mai Hatano, Waki Nakajima, Naoki Ikegaya, Tetsuya Yamamoto, Shohei Tsuchimoto, Hiroki Kato, Takuya Takahashi

    Brain communications   4 ( 2 )   fcac023   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Presurgical identification of the epileptogenic zone is a critical determinant of seizure control following surgical resection in epilepsy. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor is a major component of neurotransmission. Although elevated α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor levels are observed in surgically resected brain areas of patients with epilepsy, it remains unclear whether increased α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor-mediated currents initiate epileptic discharges. We have recently developed the first PET tracer for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor, [11C]K-2, to visualize and quantify the density of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors in living human brains. Here, we detected elevated [11C]K-2 uptake in the epileptogenic temporal lobe of patients with mesial temporal lobe epilepsy. Brain areas with high [11C]K-2 uptake are closely colocalized with the location of equivalent current dipoles estimated by magnetoencephalography or with seizure onset zones detected by intracranial electroencephalogram. These results suggest that epileptic discharges initiate from brain areas with increased α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, providing a biological basis for epileptic discharges and an additional non-invasive option to identify the epileptogenic zone in patients with mesial temporal lobe epilepsy.

    DOI: 10.1093/braincomms/fcac023

    PubMed

    researchmap

  • Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11C]K-2, in healthy human subjects. International journal

    Mai Hatano, Tomoyuki Miyazaki, Yoshinobu Ishiwata, Waki Nakajima, Tetsu Arisawa, Yoko Kuroki, Ayako Kobayashi, Yuuki Takada, Matsuyoshi Ogawa, Kazunori Kawamura, Ming-Rong Zhang, Makoto Higuchi, Masataka Taguri, Yasuyuki Kimura, Takuya Takahashi

    Scientific reports   11 ( 1 )   1598 - 1598   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    [11C]K-2, a radiotracer exhibiting high affinity and selectivity for α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), is suitable for the quantification of AMPARs in living human brains and potentially useful in the identification of epileptogenic foci in patients. This study aimed to estimate the radiation doses of [11C]K-2 in various organs and calculate the effective dose after injection of [11C]K-2 in healthy human subjects. Twelve healthy male subjects were registered and divided into two groups (370 or 555 MBq of [11C]K-2), followed by 2 h whole-body scans. We estimated the radiation dose of each organ and then calculated the effective dose for each subject. The highest uptake of [11C]K-2 was observed in the liver, while the brain also showed relatively high uptake. The urinary bladder exhibited the highest radiation dose. The kidneys and liver also showed high radiation doses after [11C]K-2 injections. The effective dose of [11C]K-2 ranged from 5.0 to 5.2 μSv/MBq. Our findings suggest that [11C]K-2 is safe in terms of the radiation dose and adverse effects. The injection of 370-555 MBq (10 to 15 mCi) for PET studies using this radiotracer is applicable in healthy human subjects and enables serial PET scans in a single subject.

    DOI: 10.1038/s41598-021-81002-3

    PubMed

    researchmap

  • Visualization of AMPA receptors in living human brain with positron emission tomography. International journal

    Tomoyuki Miyazaki, Waki Nakajima, Mai Hatano, Yusuke Shibata, Yoko Kuroki, Tetsu Arisawa, Asami Serizawa, Akane Sano, Sayaka Kogami, Tomomi Yamanoue, Kimito Kimura, Yushi Hirata, Yuuki Takada, Yoshinobu Ishiwata, Masaki Sonoda, Masaki Tokunaga, Chie Seki, Yuji Nagai, Takafumi Minamimoto, Kazunori Kawamura, Ming-Rong Zhang, Naoki Ikegaya, Masaki Iwasaki, Naoto Kunii, Yuichi Kimura, Fumio Yamashita, Masataka Taguri, Hideaki Tani, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Masaru Mimura, Michisuke Yuzaki, Hiroki Kato, Makoto Higuchi, Hiroyuki Uchida, Takuya Takahashi

    Nature medicine   26 ( 2 )   281 - 288   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although aberrations in the number and function of glutamate AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors are thought to underlie neuropsychiatric disorders, no methods are currently available for visualizing AMPA receptors in the living human brain. Here we developed a positron emission tomography (PET) tracer for AMPA receptors. A derivative of 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide radiolabeled with 11C ([11C]K-2) showed specific binding to AMPA receptors. Our clinical trial with healthy human participants confirmed reversible binding of [11C]K-2 in the brain according to Logan graphical analysis (UMIN000020975; study design: non-randomized, single arm; primary outcome: dynamics and distribution volumes of [11C]K-2 in the brain; secondary outcome: adverse events of [11C]K-2 during the 4-10 d following dosing; this trial met prespecified endpoints). In an exploratory clinical study including patients with epilepsy, we detected increased [11C]K-2 uptake in the epileptogenic focus of patients with mesial temporal lobe epilepsy, which was closely correlated with the local AMPA receptor protein distribution in surgical specimens from the same individuals (UMIN000025090; study design: non-randomized, single arm; primary outcome: correlation between [11C]K-2 uptake measured with PET before surgery and AMPA receptor protein density examined by biochemical study after surgery; secondary outcome: adverse events during the 7 d following PET scan; this trial met prespecified endpoints). Thus, [11C]K-2 is a potent PET tracer for AMPA receptors, potentially providing a tool to examine the involvement of AMPA receptors in neuropsychiatric disorders.

    DOI: 10.1038/s41591-019-0723-9

    PubMed

    researchmap

▼display all

Awards

  • SNMMI Young Investigator Award

    2023.6   Society of Nuclear Medicine and Molecular Imaging (SNMMI)   Characterization of four major psychiatric disorders based on AMPA receptor distributions measured with [11C]K-2: a novel PET tracer study

     More details

  • International Best Abstract Award

    2023.6   Society of Nuclear Medicine and Molecular Imaging (SNMMI)   Characterization of four major psychiatric disorders based on AMPA receptor distributions measured with [11C]K-2: a novel PET tracer study

     More details